Reuters logo
BRIEF-Medrx signs drug development and sale contract with Cipla USA Inc
April 6, 2017 / 6:45 AM / 8 months ago

BRIEF-Medrx signs drug development and sale contract with Cipla USA Inc

April 6 (Reuters) - Medrx Co Ltd :

* Says the company enters into a license contract with an India-based pharma Cipla Ltd’s wholly owned US-based unit Cipla USA Inc, on development and sale of MRX-4TZT, transdermal patch for the treatment of spastic paralysis

Source text in Japanese: goo.gl/8LUJTd

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below